MSCI USA IMI Biotech Advance Index

The MSCI USA IMI Biotech Advance Index aims to represent the performance of a set of companies across large, mid and small cap representation in the US market, that are associated with research, development, and commercialization of products for treating a broad range of diseases and disorders.
Get in touch
Document downloads
Index code
753365
Inception date
Nov. 30, 2016
Benchmark administrator
Div Yld (%)
0.85
P/E
123.71
P/E Fwd
43.94
P/BV
5.51
Number of constituents
100
Index Market Cap
$2.03 T
Largest constituent Market Cap
$244.78 B
Smallest constituent Market Cap
$121.80 M
Average constituent Market Cap
$20.39 B
Median constituent Market Cap
$5.50 B
Does this benchmark pursue ESG objectives?
No
Data as of Jan. 31, 2025 

ESG metrics

No data available for this index

Want to learn more about MSCI indexes?
Get in touch.

Contact us